Krüppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene.

FASEB J

Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina

Published: December 2014


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

KLF6 is a member of the Krüppel-like factor family of transcription factors, with diverse roles in the regulation of cell physiology, including proliferation, signal transduction, and apoptosis. Mutations or down-regulation of KLF6 have been described in several human cancers. In this work, we found that KLF6-knockdown resulted in the formation of transformed foci and allowed the spontaneous conversion of NIH3T3 cells to a tumorigenic state. We further assessed the role of KLF6 in the context of oncogenic Ras. We showed that KLF6 was up-regulated by H-Ras(G12V) expression in a Jun N-terminal kinase (JNK)-dependent manner, correlated with enhanced klf6 promoter activity. We found that ectopic KLF6 expression induced a G1-phase cell cycle arrest, thereby decreasing the cell proliferation rate. In addition, constitutive KLF6 expression impaired H-Ras(G12V)-mediated loss of density-dependent growth inhibition and anchorage-independent growth. Moreover, growth of H-Ras(G12V)-driven tumors was reduced in mice challenged with cells stably expressing KLF6. KLF6 expression correlated with the up-regulation of p21, whereas neither p53 induction nor apoptotic cell death was detected. Further, p21 knockdown impaired KLF6-induced cell cycle arrest. These findings provide novel evidence highlighting KLF6 function in response to malignant transformation, suggesting the relevance of KLF6 in controlling cell proliferation and hindering tumorigenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.14-251884DOI Listing

Publication Analysis

Top Keywords

klf6 expression
12
klf6
11
krüppel-like factor
8
cell cycle
8
cycle arrest
8
cell proliferation
8
cell
6
factor interferes
4
interferes cellular
4
cellular transformation
4

Similar Publications

Interferon-gamma (IFN-γ) is a key regulator of immune responses. A hallmark of IFN-γ responses is inducible nitric oxide (NO), driven primarily by nitric oxide synthase (NOS)2. In this study, we investigated the influence of NO on the IFN-γ-induced transcriptomic and metabolic changes in the RAW 264.

View Article and Find Full Text PDF

KLF6 enhances ferroptosis in S-AKI through the NCOA4/ACSL4/LPCAT3 axis.

Int Immunopharmacol

August 2025

Intensive Care Unit, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China; The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, China.

Background: Septic acute kidney injury (S-AKI) is a major cause of acute kidney injury (AKI), but no effective therapies exist to prevent or treat it. Although KLF6 is linked to various pathophysiological processes, its exact role in S-AKI is not yet fully understood.

Methods: The role of KLF was investigated using both the mouse CLP model and in vitro systems.

View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC), a prevalent and highly lethal malignancy, is notorious for its aggressive nature and inherent tendency to metastasize, posing significant challenges in clinical management and prognosis. Hypoxia, a pivotal characteristic of the tumor microenvironment (TME) in hepatocellular HCC, is intimately linked to disease progression and unfavorable patient outcomes, underscoring its critical role in shaping the malignant behavior of this cancer.

Methods: Our research leveraged single-cell RNA sequencing technology to dissect the heterogeneity of the HCC TME, focusing on hypoxia-related genes.

View Article and Find Full Text PDF

Expression of Concern.

Eur Rev Med Pharmacol Sci

June 2025

Not available.

The Publisher, in agreement with the Editor-in-Chief, is issuing this Expression of Concern to inform readers that a formal investigation is currently underway regarding a set of published articles. Despite multiple attempts to contact the corresponding authors, we have not received any response to date. Further editorial actions, such as retraction or correction, will be taken as appropriate in due course.

View Article and Find Full Text PDF

Trichosanthis Pericarpium injection ameliorates non-alcoholic fatty liver disease via inhibiting the KLF6/ABCC5 pathway in mice.

Phytomedicine

September 2025

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Key Laboratory for Digestive Organ Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Electronic addre

Background: Trichosanthis Pericarpium injection (TPI) exhibits notable therapeutic effects on cardiovascular disease caused by phlegm-turbidity (tan zhuo), yet its impact on non-alcoholic fatty liver disease (NAFLD) which has similarly resulted by phlegm-turbidity remains largely unexplored. This study investigates the ameliorative effects of TPI on NAFLD and elucidates its underlying mechanisms.

Methods: This study was conducted both in vivo and in vitro using a mouse model of NAFLD and oleic acid (OA)-stimulated AML-12 cells, respectively.

View Article and Find Full Text PDF